| |
| |
|
| Insider
Information: |
Mcdonnell Michael R |
| Relationship: |
|
| City: |
Englewood |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
422,801 |
|
|
Indirect Shares
|
320 |
|
|
| Direct
Value |
$8,902,875 |
|
|
|
Indirect Value
|
$1,846 |
|
|
| Total
Shares |
423,121 |
|
|
| Total
Value |
$8,904,721 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 62.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dish Network Corporation |
DISH |
Former EVP, CFO |
2004-09-07 |
400 |
2004-09-07 |
320 |
Premium* |
|
|
MCG Capital Corp |
MCGC |
EVP, CFO & COO |
2008-04-30 |
338,200 |
2005-05-09 |
0 |
Premium* |
|
|
IQVIA Holdings Inc |
IQV |
EVP and CFO |
2020-07-05 |
18,966 |
2015-12-16 |
0 |
Premium* |
|
|
Ims Health Holdings, Inc. |
IMS |
EVP and CFO |
2017-07-05 |
40,517 |
2017-07-05 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
EVP, Chief Financial O... |
2024-02-16 |
19,406 |
2021-09-01 |
0 |
Premium* |
|
|
Merit Medical Systems Inc |
MMSI |
|
2023-05-18 |
5,312 |
2022-05-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
EVP, Chief Financial Officer |
• • – |
2024-02-16 |
4 |
D |
$219.08 |
$753,197 |
D/D |
(3,438) |
19,406 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Financial Officer |
• • – |
2024-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,720 |
20,507 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Financial Officer |
• • – |
2024-02-09 |
4 |
D |
$240.98 |
$344,842 |
D/D |
(1,431) |
16,124 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Financial Officer |
• • – |
2024-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,257 |
17,555 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Financial Officer |
• • – |
2024-02-08 |
4 |
D |
$240.30 |
$183,830 |
D/D |
(765) |
14,298 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Financial Officer |
• • – |
2024-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,335 |
15,063 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Financial Officer |
• • – |
2023-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,285 |
14,060 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Financial Officer |
• • – |
2023-09-01 |
4 |
D |
$267.17 |
$722,428 |
D/D |
(2,704) |
12,728 |
0 |
- |
|
| MMSI |
Merit Medical Systems Inc |
|
– • – |
2023-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,262 |
5,312 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Financial Officer |
• • – |
2023-02-17 |
4 |
D |
$278.38 |
$364,678 |
D/D |
(1,310) |
7,586 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Financial Officer |
• • – |
2023-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,561 |
10,147 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Financial Officer |
• • – |
2023-02-10 |
4 |
D |
$286.30 |
$316,362 |
D/D |
(1,105) |
8,896 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Financial Officer |
• • – |
2023-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,256 |
10,001 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Financial Officer |
• • – |
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,746 |
7,801 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Financial Officer |
• • – |
2022-09-01 |
4 |
D |
$199.79 |
$485,090 |
D/D |
(2,428) |
6,745 |
0 |
- |
|
| MMSI |
Merit Medical Systems Inc |
|
– • – |
2022-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,050 |
3,050 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Financial Officer |
• • – |
2022-02-18 |
4 |
D |
$209.79 |
$204,965 |
D/D |
(977) |
4,427 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Financial Officer |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,981 |
5,404 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Financial Officer |
• • – |
2021-09-01 |
4 |
D |
$338.24 |
$873,336 |
D/D |
(2,582) |
3,423 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Financial Officer |
• • – |
2021-09-01 |
4 |
OE |
$338.24 |
$2,031,131 |
D/D |
6,005 |
4,864 |
0 |
- |
|
| IQV |
IQVIA Holdings Inc |
EVP and CFO |
• – – |
2020-07-05 |
4 |
D |
$141.52 |
$390,878 |
D/D |
(2,762) |
18,966 |
0 |
- |
|
| IQV |
IQVIA Holdings Inc |
EVP and CFO |
• – – |
2020-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
12,728 |
27,094 |
0 |
- |
|
| IQV |
IQVIA Holdings Inc |
EVP and CFO |
• – – |
2020-02-11 |
4 |
D |
$161.70 |
$867,682 |
D/D |
(5,366) |
21,728 |
0 |
- |
|
| IQV |
IQVIA Holdings Inc |
EVP and CFO |
• – – |
2020-01-02 |
4 |
AS |
$155.07 |
$1,860,840 |
D/D |
(12,000) |
14,366 |
0 |
% |
|
| IQV |
IQVIA Holdings Inc |
EVP and CFO |
• – – |
2019-07-05 |
4 |
D |
$160.90 |
$389,217 |
D/D |
(2,419) |
26,366 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
